How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Vitamin B5 Serum Market
- By Product Form: Liquid Serum, Gel Serum, Cream Serum, Oil-based Serum
- By Distribution Channel: Online Retail, Specialty Stores, Pharmacies and Drugstores, Supermarkets and Hypermarkets, Beauty Salons and Spas
- By End User: Women, Men, Unisex
- By Application: Anti-Aging, Moisturizing, Skin Repair, Brightening, Acne Treatment
- By Price Range: Mass Market, Premium, Luxury
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Liquid Serum leads By Product Form at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 296 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.178 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.186 →
Full report · locked preview
Everything inside the Vitamin B5 Serum Market report
A complete, evidence-based study - 12 chapters and 124 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Product Form 4
Distribution Channel 5
End User 3
Application 5
Price Range 3
Companies profiled
L'Oréal S.A.
Estée Lauder Companies Inc.
Unilever PLC
Procter & Gamble Co.
Shiseido Company
Limited
Beiersdorf AG
Amorepacific Corporation
Coty Inc.
Johnson & Johnson Consumer Inc.
The Hain Celestial Group Inc.
The Inkey List
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →L'Oréal S.A.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Estée Lauder Companies Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Unilever PLC
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Procter & Gamble Co.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Shiseido Company
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Limited
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Beiersdorf AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Amorepacific Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Coty Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Johnson & Johnson Consumer Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →The Hain Celestial Group Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →The Inkey List
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Paula's Choice
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →The Ordinary (DECIEM)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Biossance
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Drunk Elephant
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$1,837M by 2033 · 8.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Liquid Serum57.1
- Gel Serum18.5
- Cream Serum10.1
- Oil-based Serum14.3
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$315.9M → $556.8M · 7.3%
Europe$220.2M → $463.1M · 9.7%
Asia Pacific$201.0M → $360.5M · 7.6%
Latin America$124.5M → $221.1M · 7.4%
Middle East and Africa$95.7M → $169.8M · 7.4%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →8.442026
8.442027
8.462028
8.472029
8.482030
8.502031
8.512032
8.522033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- L'Oréal S.A.9.5
- Estée Lauder Companies Inc.20.5
- Unilever PLC8.1
- Procter & Gamble Co.10.7
- Shiseido Company10.4
- Limited12.7
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Form25.8%
Distribution Channel10.7%
End User21.1%
Application13.5%
Price Range28.8%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.4
- Europe26.1
- Asia Pacific20.4
- Latin America12.5
- Middle East and Africa9.6
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| L'Oréal S.A. | 87 | 75 | 92 | 79 | 87 | 75 | 83 |
| Estée Lauder Companies Inc. | 81 | 77 | 88 | 80 | 72 | 79 | 80 |
| Unilever PLC | 65 | 72 | 87 | 74 | 72 | 72 | 74 |
| Procter & Gamble Co. | 65 | 66 | 64 | 78 | 65 | 66 | 67 |
| Shiseido Company | 69 | 61 | 58 | 53 | 69 | 57 | 61 |
| Limited | 63 | 51 | 49 | 63 | 66 | 54 | 58 |
| Beiersdorf AG | 59 | 54 | 43 | 65 | 59 | 58 | 56 |
| Amorepacific Corporation | 52 | 60 | 42 | 43 | 57 | 60 | 52 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- L'Oréal S.A.
- Estée Lauder Companies Inc.
- Unilever PLC
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| L'Oréal S.A. | ✓ | ◐ | ◐ | ✓ | ◐ | ◐ |
| Estée Lauder Companies Inc. | ◐ | ◐ | ✓ | ✓ | ◐ | ◐ |
| Unilever PLC | ◐ | ◐ | ✓ | ◐ | ◐ | ◐ |
| Procter & Gamble Co. | ◐ | ◐ | ◐ | ◐ | − | − |
| Shiseido Company | − | ◐ | ◐ | − | ◐ | ◐ |
| Limited | ◐ | − | ◐ | ◐ | ◐ | − |
| Beiersdorf AG | ◐ | − | − | ◐ | − | − |
| Amorepacific Corporation | − | ◐ | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1L'Oréal S.A.83
2Estée Lauder Companies Inc.80
3Unilever PLC74
4Procter & Gamble Co.67
5Shiseido Company61
6Limited58
7Beiersdorf AG56
8Amorepacific Corporation52
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
L'Oréal S.A.Estée Lauder Companies Inc.
Challenger2
Strong scale, closing on the leaders.
Unilever PLCProcter & Gamble Co.
Contender2
Focused players with pockets of strength.
Shiseido CompanyLimited
Niche2
Specialists in a single segment or region.
Beiersdorf AGAmorepacific Corporation
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Form in North America, then scale across Vitamin B5 Serum Market — a $533M beachhead inside a $8.55B market.
Beachhead (SOM)$533Mobtainable near-term
Serviceable (SAM)$2.92Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion92 fit
Liquid Serum
Best fit — highest urgency & budget in Product Form.
Economic buyer80 fit
Gel Serum
Strong fit — clear ROI and a fast path to value.
End user65 fit
Cream Serum
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Form in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Distribution Channel & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel26%
Digital / self-serve22%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Product Form leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Vitamin B5 Serum Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified38%
Sales qualified22%
Evaluation15%
Closed-won7%
$16.4KCAC
$74KLTV
4.5:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Vitamin B5 Serum Market is a durable-growth opportunity — $796M by 2033, compounding at 7.6%.
TAM · 2025$443Mtoday
TAM · 2033$796Mforecast
CAGR7.6%2027–2033
Cumulative$5.44Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$796MTotal addressable market
SAM$281MServiceable available market
SOM$50MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →7.6% CAGR
Demand compounds through 2033, outpacing GDP across Product Form.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Form moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$796MLarge & growingTAM by 2033 at 7.6% CAGR
$281MServiceable nowreachable with today’s model
$50MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$621MBear4.9% CAGR
$796MBase7.6% CAGR
$1.02BBull10.0% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Distribution Channel optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Vitamin B5 Serum Market — a $11.2B market by 2033. Plan: grow share from 6.1% to 11.6%.
Market size · 2033$11.2Btotal addressable
Market CAGR11.5%2027–2033
Target share11.6%from 6.1% today
Revenue ambition$1.30Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.1% | 11.6% | On track |
| Revenue | $698M | $1.30B | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 36.8% | 42.3% | Behind |
| Customer retention | 87.8% | 96.6% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Form
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Distribution Channel capability
A defensible second engine — invest in Distribution Channel to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Form share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Distribution Channel
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $195M capacity & capability investment
- Greenlight bolt-on M&A in Distribution Channel
- Authorise North America expansion plan
- Fund R&D program for Product Form leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossAt risk
- Input-cost & supply riskAhead
- Regulatory / policy changeAhead
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Vitamin B5 Serum Market conversation — a $5.48B market you can size, segment and defend in minutes.
Market size · 2033$5.48Btotal opportunity
Growth3.8%CAGR to 2033
Addressable buyers1,202+accounts in scope
Typical ROI6.8×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Form
Goal Grow share in Product Form
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.8×return on cost, year one
< 4 mopayback period
$91K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
L'Oréal S.A.Estée Lauder Companies Inc.Unilever PLCProcter & Gamble Co.Shiseido CompanyLimitedBeiersdorf AGAmorepacific Corporation+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Vitamin B5 Serum Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Vitamin B5 Serum Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Vitamin B4 Active Pharmaceutical Ingredient Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportVitamin B3 (Nicotinamide) Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportVitamin B3 Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportVitamin B2 (Riboflavin) Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportVitamin B2 API Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportVitamin B1 (Thiamine Hydrochloride) Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportVitamin B1 Injection Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportVitamin B12 Drops Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportVitamin B12 Deficiency Treatment Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportVitamin B12 (Cyanocobalamin) Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportVitamin A Supplements Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportVitamin API Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.